Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Savannah, Georgia

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research – Savannah is a dedicated clinical trial research site located in Savannah, Georgia, United States. The site is part of the global Velocity Clinical Research network, an integrated site organization that partners with pharmaceutical, biotechnology, and medical device companies to conduct clinical trials for the development of new therapies and medical technologies. Through its extensive network of sites, Velocity focuses on accelerating clinical research while maintaining high standards of patient safety, regulatory compliance, and data quality. The Savannah facility conducts Phase II–IV clinical trials across multiple therapeutic areas including internal medicine, vaccines, infectious diseases, endocrinology, and metabolic disorders. The center collaborates with experienced physician investigators and trained clinical research coordinators to ensure efficient study execution and reliable data collection. Equipped with modern research infrastructure,…

Source: Trial-derived.
77Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
16Active Trials
Source: Trial-derived.
55Completed Trials
Source: Trial-derived.
67Unique Conditions
Source: Trial-derived.
42Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Migraine (9)Source: Trial-derived. Episodic Migraine (4)Source: Trial-derived. Respiratory Syncytial Virus (4)Source: Trial-derived. Heart Failure (3)Source: Trial-derived. Influenza, Human (3)Source: Trial-derived. Pneumococcal Disease (3)Source: Trial-derived. Seasonal Influenza (3)Source: Trial-derived. Atopic Dermatitis (2)

Sponsors

Source: Trial-derived. Pfizer (12)Source: Trial-derived. ModernaTX, Inc. (11)Source: Trial-derived. AbbVie (6)Source: Trial-derived. Eli Lilly and Company (6)Source: Trial-derived. Boehringer Ingelheim (4)Source: Trial-derived. Sanofi (4)Source: Trial-derived. Seqirus (3)Source: Trial-derived. Allergan (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. PET-CT
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PBMC isolation & cryopreservation

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD19+ B-cell quantification
Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. ELISpot assay
Source: AI-inferred. Electronic participant diary (eDiary) system
Source: AI-inferred. Electronic patient-reported outcome (ePRO) device system
Source: AI-inferred. Hemagglutination inhibition (HAI) antibody assay
Source: AI-inferred. Hemagglutination inhibition (HAI) assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay